| CZWI | PRESS-RELEASE | bearish | 6/10 | Citizens Community Bancorp reported Q2 2026 GAAP EPS of $0.11, a 73% miss versus the $0.41 consensus, driven by a $4.33 | Jul 27, 2026 |
| CARR | PRESS-RELEASE | neutral | 4/10 | Carrier announced the sale of its NORESCO business to OPTERRA Energy Services (a subsidiary of LS Power). The deal is ex | Jul 27, 2026 |
| RZLV | PRESS-RELEASE | bullish | 6/10 | Rezolve AI reported preliminary H1 2026 revenue of ~$127M, a 20x increase from $6.32M in H1 2025, already exceeding full | Jul 27, 2026 |
| BCAL | PRESS-RELEASE | bullish | 7/10 | California BanCorp (BCAL) reported Q2 2026 EPS of $0.44, beating the $0.40 consensus by 10% (a strong beat), with net in | Jul 27, 2026 |
| NBN | PRESS-RELEASE | neutral | 5/10 | Northeast Bank reported Q4 2026 diluted EPS of $4.05, beating the $3.40 consensus by 19.1%, driven by record loan origin | Jul 27, 2026 |
| PDLB | PRESS-RELEASE | neutral | 5/10 | Ponce Financial Group reported Q2 2026 net income available to common stockholders of $8.2M ($0.35 diluted EPS), slightl | Jul 27, 2026 |
| KEEL | PRESS-RELEASE | neutral | 1/10 | Keel Infrastructure announced it will host a conference call on August 10, 2026 to discuss its Q2 2026 results. | Jul 27, 2026 |
| SHAZ | PRESS-RELEASE | neutral | 1/10 | Sharon AI Holdings Inc. announced it will report its Q2 2026 results on August 6, 2026. | Jul 27, 2026 |
| TDG | PRESS-RELEASE | neutral | 4/10 | TransDigm Group announced the acquisition of Prince & Izant, a manufacturer of brazing alloys and specialty metal compon | Jul 27, 2026 |
| HCTI | PRESS-RELEASE | neutral | 3/10 | Healthcare Triangle announced the creation of a wholly owned AI-led subsidiary, Purpose Health, and appointed veteran he | Jul 27, 2026 |
| CMRE | PRESS-RELEASE | mixed | 5/10 | Costamare reported Q2 2026 GAAP EPS of $0.64, beating consensus of $0.48 by 33.3%, and voyage revenue of $200.8M, beatin | Jul 27, 2026 |
| HBT | PRESS-RELEASE | bullish | 6/10 | HBT Financial reported strong Q2 2026 results with net income of $27.8M ($0.76 diluted EPS), up from $19.2M ($0.61) in Q | Jul 27, 2026 |
| AZ | PRESS-RELEASE | neutral | 1/10 | A2Z Cust2Mate Solutions Corp. announced it will report its Q2 2026 results on August 12, 2026. | Jul 27, 2026 |
| HROW | PRESS-RELEASE | neutral | 1/10 | Harrow, Inc. announced it will report its Q2 2026 results on August 10, 2026. | Jul 27, 2026 |
| MRX | PRESS-RELEASE | neutral | 1/10 | Marex Group Limited announced it will report its Q2 2026 results on August 12, 2026. | Jul 27, 2026 |
| PPHC | PRESS-RELEASE | neutral | 1/10 | Public Policy Holding Company, Inc. announced it will report its Q2 2026 results on August 10, 2026. | Jul 27, 2026 |
| LGN | PRESS-RELEASE | neutral | 1/10 | Legence Corp announced it will report its Q2 2026 results on August 13, 2026. | Jul 27, 2026 |
| LKFN | PRESS-RELEASE | neutral | 5/10 | Lake City Bank (LKFN) reported Q2 2026 diluted EPS of $1.13, beating the $1.07 consensus by 5.6%, and revenue of $70.9M | Jul 27, 2026 |
| TNXP | PRESS-RELEASE | neutral | 1/10 | Tonix Pharmaceuticals Holding Corp. announced it will report its Q2 2026 results on August 10, 2026. | Jul 27, 2026 |
| NMRA | PRESS-RELEASE | bullish | 7/10 | Neumora Therapeutics announced favorable pre-clinical toxicology results for NMRA-215, a brain-penetrant oral NLRP3 inhi | Jul 27, 2026 |
| ENSG | PRESS-RELEASE | bullish | 7/10 | The Ensign Group reported Q2 2026 GAAP diluted EPS of $1.68 (up 16.7% YoY) and adjusted EPS of $1.92 (up 20.8% YoY), wit | Jul 27, 2026 |
| ALLT | PRESS-RELEASE | neutral | 1/10 | Allot announced it will report its Q2 2026 results on August 12, 2026. | Jul 27, 2026 |
| LEGN | PRESS-RELEASE | neutral | 4/10 | Legend Biotech CEO Ying Huang stepped down effective July 24, 2026; Alan Bash, President of the CARVYKTI Business Unit, | Jul 27, 2026 |
| KBR | PRESS-RELEASE | bullish | 5/10 | KBR announced it has been awarded a Project Management Consultant (PMC) contract by Power2X for a large-scale eFuels pro | Jul 27, 2026 |
| RACE | PRESS-RELEASE | neutral | 2/10 | Ferrari disclosed weekly buyback activity under its €3.5B multi-year program, repurchasing 57,800 shares on the EXM for | Jul 27, 2026 |
| HSAI | PRESS-RELEASE | neutral | 1/10 | Hesai Group announced it will report its Q2 2026 results on August 18, 2026. | Jul 27, 2026 |
| ARGX | PRESS-RELEASE | bullish | 7/10 | argenx is acquiring Forte Biosciences for $77/share in cash, total equity value ~$2.2B, an 86% premium to Forte's VWAP s | Jul 27, 2026 |
| NCTY | PRESS-RELEASE | bullish | 7/10 | The9 Limited reported Q1 2026 net income of $23 million, its strongest quarter since IPO, driven by digital asset gains | Jul 27, 2026 |
| SVCO | PRESS-RELEASE | bullish | 6/10 | Silvaco announced a collaboration with NVIDIA to integrate NVIDIA accelerated computing, AI, and digital twin platforms | Jul 26, 2026 |
| AAPG | PRESS-RELEASE | neutral | 1/10 | Ascentage Pharma's Chairman and CEO, Dr. Dajun Yang, was ranked No. 3 in The Medicine Maker Power List 2026 Small Molecu | Jul 26, 2026 |